Published by Alexander Bueso on 16th December 2020
(Sharecast News) - Standard&Poor's placed its rating on AstraZeneca's long-term corporate debt on so-called Credit Watch Positive following news of its intended purchase of US rare disease specialist Alexion.
URL: http://www.digitallook.com/dl/news/story/31520875/...